Potential risk factors associated with thrombocytopenia in a surgical intensive care unit

Pharmacotherapy

Volumn 19, Issue 1 I, 1999, Pages 108-113

  Cawley, Michael J ^a   Wittbrodt, Eric T ^a   Boyce, Eric G ^a   Skaar, Debra J ^b  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b Merck Medco Managed Care Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; CARBAPENEM; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; ENOXAPARIN; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; PENICILLIN DERIVATIVE; PHENYTOIN; PIPERACILLIN; UREIDOPENICILLIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; DRUG INDUCED DISEASE; DRUG USE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; RISK FACTOR; SEIZURE; SEPSIS; STRESS ULCER; SURGICAL PATIENT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTENSIVE CARE; LINEAR MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOCYTOPENIA;

EID: 0032917539     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.1.108.30518     Document Type: Article

References (29)

1. Baughman RP, Lower EE, Flessa HC, et al. Thrombocytopenia in the intensive care unit. Chest 1993;104:1243-7.
2. Hanes SD, Quarles DA, Boucher BA. Incidence and risk factors of thrombocytopenia in critically ill trauma patients. Ann Pharmacother 1997;31:285-9.
3. Bonfiglio MF, Traeger SM, Kier KL, et al. Thrombocytopenia in intensive care patients: a comprehensive analysis of risk factors in 314 patients. Ann Pharmacother 1995;29:835-42.
4. Bogdononoff DL, Williams ME, Stone DJ. Thrombocytopenia in the critically ill patient. J Crit Care 1990;5:186-205.
5. Riska EB, Bostman O, von Bonsdorff H, et al. Outcome of closed head injuries exceeding 20-unit blood transfusion need. Injury 1988;19:273-6.
6. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
7. Nearne PB, Kelton JG, Walker IR, et al. Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood 1980;56:88-92.
8. Wilson JJ, Nearne PB, Kelton JK. Infection-induced thrombocytopenia. Semin Thromb Hemost 1982;8:217-33.
9. 2-receptor antagonists: an update. Pharmacotherapy 1987;7(suppl):110S-15.
10. Yue CP, Mann KS. Severe thrombocytopenia due to combined cimetidine and phenytoin therapy. Neurosurgery 1987;20:963-5.
11. Missri J. Hematologic toxicity of drugs used in cardiovascular disease. Postgrad Med 1979;65:171-2.
12. Zenon GJ, Cadle RM, Hamill RJ. Vancomycin-induced thrombocytopenia. Arch Intern Med 1991;151:995-6.
13. Landrum EM, Eeigert EA, Hanlon JT, et al. Prolonged thrombocytopenia associated with procainamide in an elderly patient. Ann Pharmacother 1994;28:1172-6.
14. Magnoni HN. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaron (ORG 10172). Thromb Haemost 1993;70:554-61.
15. Hagen MD. Thrombocytopenia secondary to trimethoprimsulfamethoxazole. South Med J 1983;76:503.
16. Howrie DL, Schwinghammer TL, Wollman M. Use of IV immune globulin for treatment of phenytoin-induced thrombocytopenia. Clin Pharm 1989;8:734-7.
17. Kim YL, Richman KA, Marshall BE. Thrombocytopenia associated with Swan-Ganz catheterization in patients. Anesthesiology 1980;53:261-2.
18. Howard CE, Adams LA, Admire JL, Chu MA, Alred GL. Vancomycin-induced thrombocytopenia: a challenge and rechallenge. Ann Pharmacother 1997;31:315-18.
19. Mizon P, Kiefel V, Mannessier L, Mueller-Eckhardt C, Goudemand J. Thrombocytopenia induced by vancomycin-dependent platelet antibody. Vox Sang 1997;73:49-51.
20. Kishimoto T. Vancomycin-induced thrombocytopenia for MRSA pneumonia. Rinsho Ketsueki 1995;36:768-73.
21. Olivera E, Lakhani P, Watanakunakorn C. Isolated severe thrombocytopenia and bleeding caused by piperacillin. Scand J Infect Dis 1992;24:815-17.
22. Lang R, Lishner M, Ravid M. Adverse reactions to prolonged treatment with high doses of carbenicillin. Rev Infect Dis 1991;13:68-72.
23. Holtzer CD, Reisner-Keller LA. Phenytoin-induced thrombocytopenia. Ann Pharmacother 1997;31:435-7.
24. Wyllie E, Wyllie R. Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy. Epilepsia 1991;32(suppl 5):S74-9.
25. Schweiger FJ, Kelton JG, Messner H, et al. Anticonvulsant-induced marrow suppression and immune thrombocytopenia. Acta Haematol 1988;80:54-8.
26. Cate H, Brandjes D, Wolters HJ, van Deventer S. Disseminated intravascular coagulation: pathophysiology, diagnosis, and treatment. New Horizons 1993;2:312-23.
27. Noe DA, Graham SM, LuffR, Sohmer P. Platelet counts during rapid massive transfusions. Transfusion 1982;22:392-5.
28. Garratty G. Immune cytopenia associated with antibiotics. Transfus Med Rev 1993;7:255-67.
29. Lubran MM. Hematologic side effects of drugs. Ann Clin Lab Sci 1989;19:114-21.